Corrigendum to “Risk factors for developing mineral bone disease in phenylketonuric patients” [Mol. Genet. Metab. 108 (2013) 149–154]

Corrigendum to “Risk factors for developing mineral bone disease in phenylketonuric patients” [Mol. Genet. Metab. 108 (2013) 149–154] Alicia Miras, M. Dolores Boveda, Maria R. Leis, Antonio Mera, Luis Aldamiz-Echevarria, Jose R. Fernandez-Lorenzo, Jose M. Fraga, Maria L. Couce⁎ a Unit of Diagnosis and Treatment of CongenitalMetabolic Diseases, Department of Pediatrics, Hospital Clinico Universitario de Santiago, Travesia da Choupana s/n, 15706 Santiago de Compostela, A Coruna, Spain b Unit of Diagnosis and Treatment of Congenital Metabolic Diseases, Metabolic Laboratory, Hospital Clinico Universitario de Santiago, Travesia da Choupana s/n, 15706 Santiago de Compostela, A Coruna, Spain c Unit of Nutrition and Metabolism, Department of Pediatrics, Hospital Clinico Universitario de Santiago, Travesia da Choupana s/n, 15706 Santiago de Compostela, A Coruna, Spain d Rheumatology Service, Hospital Clinico Universitario de Santiago, Travesia da Choupana s/n, 15706 Santiago de Compostela, A Coruna, Spain e Unit of Metabolism, Department of Pediatrics, Hospital de Cruces, Plaza de Cruces s/n, 48903 Barakaldo, Vizcaya, Spain f Pediatric Service, Hospital Xeral Cies, C/Pizarro 2, 36204 Vigo, Spain g Unit of Diagnosis and Treatment of Congenital Metabolic Diseases, Department of Pediatrics, Hospital Clinico Universitario de Santiago de Compostela, CIBERER, Health Research Institute of Santiago de Compostela (IDIS), A Choupana, s/n, 15706 Santiago de Compostela, A Coruna, Spain